In vitro effects of brominated flame retardants and metabolites on CYP17 catalytic activity: A novel mechanism of action?
- 1 October 2006
- journal article
- Published by Elsevier in Toxicology and Applied Pharmacology
- Vol. 216 (2) , 274-281
- https://doi.org/10.1016/j.taap.2006.05.007
Abstract
No abstract availableKeywords
This publication has 49 references indexed in Scilit:
- Inhibition and Induction of Aromatase (CYP19) Activity by Brominated Flame Retardants in H295R Human Adrenocortical Carcinoma CellsToxicological Sciences, 2005
- Adrenal Androgens and the Immune SystemSeminars in Reproductive Medicine, 2004
- Metabolism in the toxicokinetics and fate of brominated flame retardants—a reviewEnvironment International, 2003
- Toxic effects of brominated flame retardants in man and in wildlifeEnvironment International, 2003
- An overview of commercially used brominated flame retardants, their applications, their use patterns in different countries/regions and possible modes of releaseEnvironment International, 2003
- Dehydroepiandrosterone inhibits the expression of carcinogen‐activating enzymes in vivoInternational Journal of Cancer, 2003
- An overview of brominated flame retardants in the environmentChemosphere, 2002
- Polybrominated Diphenyl Ethers: Occurrence, Dietary Exposure, and ToxicologyEnvironmental Health Perspectives, 2001
- Identification and Quantification of Polybrominated Diphenyl Ethers and Methoxy-Polybrominated Diphenyl Ethers in Baltic BiotaEnvironmental Science & Technology, 1997
- Rapid colorimetric assay for cell growth and survivalJournal of Immunological Methods, 1986